31.95
-0.265(-0.82%)
Currency In USD
| Previous Close | 32.21 |
| Open | 32.38 |
| Day High | 32.38 |
| Day Low | 31.05 |
| 52-Week High | 46.48 |
| 52-Week Low | 21.16 |
| Volume | 1.15M |
| Average Volume | 2.12M |
| Market Cap | 5.07B |
| PE | 84.07 |
| EPS | 0.38 |
| Moving Average 50 Days | 32.96 |
| Moving Average 200 Days | 34.38 |
| Change | -0.27 |
If you invested $1000 in TG Therapeutics, Inc. (TGTX) 10 years ago, it would be worth $2,789.96 as of September 08, 2025 at a share price of $31.945. Whereas If you bought $1000 worth of TG Therapeutics, Inc. (TGTX) shares 5 years ago, it would be worth $1,333.26 as of September 08, 2025 at a share price of $31.945.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
GlobeNewswire Inc.
5 hours ago
Phase 3 trial to evaluate two subcutaneous BRIUMVI dosing regimensNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (u
TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 04, 2025 11:30 AM GMT
Fireside chat scheduled for Monday, September 8, 2025, at 10:30am ETNEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will pa
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program
GlobeNewswire Inc.
Sep 03, 2025 11:30 AM GMT
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that it has completed its previously authorized $100 million share repurchase program, which was initially announced in August 2024. Under that progra